市场调查报告书
商品编码
1521297
2024-2032年按材料(玻璃、玻璃陶瓷、复合材料等)、类型(粉末、可模塑、颗粒等)、应用(牙科、外科、生物工程等)和地区分類的生物活性材料市场Bioactive Materials Market by Material (Glass, Glass-ceramics, Composite, and Others), Type (Powder, Moldable, Granules, and Others), Application (Dentistry, Surgery, Bioengineering, and Others), and Region 2024-2032 |
IMARC Group年全球生物活性材料市场规模达28亿美元。对再生医学不断增长的需求、开发具有增强性能的新型和改进的生物活性材料以及生物技术和生命科学领域的不断改进是推动市场的一些关键因素。
生物活性材料是指与生物系统(例如细胞、组织和器官)相互作用的成分。这些材料可以是合成的或天然的,主要用于各种医疗应用,包括组织工程、药物传输和再生医学。它们可以透过模仿目标组织的细胞外基质(ECM)来促进特定的生物反应,例如细胞黏附、增殖和分化。此外,它们还可以用于药物输送,其中材料被设计成随着时间的推移释放药物或治疗剂。这对于标靶药物传递非常有用,药物可以直接释放到受影响的组织,最大限度地减少副作用并提高疗效。因此,它们在全球范围内获得了广泛的关注,因为生物活性材料在医学领域具有广泛的应用,并且是推动各种疾病和病症治疗的重要工具。一些常见的生物活性材料包括羟基磷灰石和聚己内酯 (PCL),它们广泛用于骨移植和牙科植入物,并用于创建促进新组织生长的支架。
全球市场主要是由患者和医疗保健专业人员对再生医学不断增长的需求所推动的。再加上慢性病在个人中的盛行率不断增加,导致对创新治疗方案的需求不断增长,这推动了对促进组织再生和修復的生物活性材料的需求。同时,生物活性材料领域的不断技术进步以及具有增强特性(例如生物相容性、生物可降解性和机械强度)的新型和改进材料的开发正在创造积极的市场前景。此外,为开发新材料和应用而进行的广泛研发(R&D)活动的投资不断增加,也是一个成长诱导因素。除此之外,私人和公共机构为升级整体医疗基础设施而不断增加的资金正在对市场产生积极影响。同时,生物技术和生命科学领域的不断进步极大地支持了全球对生物活性材料的需求。其他因素,包括快速城市化、不断增长的老年人口以及农村和其他地区医疗设施的发展,也对市场产生了积极影响。
The global bioactive materials market size reached US$ 2.8 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 7.7 Billion by 2032, exhibiting a growth rate (CAGR) of 11.44% during 2024-2032. The growing demand for regenerative medicine, the development of new and improved bioactive materials with enhanced properties and continuous improvements in the field of biotechnology and life science represent some of the key factors driving the market.
Bioactive materials are constituents that are meant to interact with biological systems, such as cells, tissues, and organs. These materials can be synthetic or natural and are mainly used in a variety of medical applications, including tissue engineering, drug delivery, and regenerative medicine. They can promote specific biological responses, such as cell adhesion, proliferation, and differentiation, by mimicking the extracellular matrix (ECM) of the tissue being targeted. Additionally, they can also be utilized for drug delivery, where the material is designed to release a drug or therapeutic agent over time. This can be useful for targeted drug delivery, where the drug is released directly to the affected tissue, minimizing side effects and improving efficacy. As a result, they are gaining widespread prominence across the globe since bioactive materials have a wide range of applications in the medical field and are an important tool for advancing treatments for various diseases and conditions. Some of the common bioactive materials include hydroxyapatite and polycaprolactone (PCL) that are widely adopted for bone grafts and dental implants and to create scaffolds that promote the growth of new tissue.
The global market is majorly driven by the growing demand for regenerative medicine among patients and healthcare professionals. Coupled with the increasing prevalence of chronic diseases among individuals, leading to a growing need for innovative treatment options, this is providing a boost to the demand for bioactive materials to promote tissue regeneration and repair. Along with this, continual technological advancements in the field of bioactive materials and the development of new and improved materials with enhanced properties, such as biocompatibility, biodegradability, and mechanical strength, are creating a positive market outlook. Furthermore, the growing investments in extensive research and development (R&D) activities to develop new materials and applications are acting as a growth-inducing factor. Apart from this, the escalating funding by private and public agencies to upgrade the overall healthcare infrastructure is impacting the market favorably. Along with this, continuous improvements in the field of biotechnology and life science are significantly supporting the demand for bioactive materials across the globe. Other factors, including rapid urbanization, the growing geriatric population and the development of medical facilities across rural and geographically extended locations, are also positively influencing the market.
IMARC Group provides an analysis of the key trends in each segment of the global bioactive materials market, along with forecasts at the global, regional, and country levels from 2024-2032. Our report has categorized the market based on material, type and application.
Glass
Glass-ceramics
Composite
Others
The report has provided a detailed breakup and analysis of the bioactive materials market based on the material. This includes glass, glass-ceramics, composites and others. According to the report, glass represented the largest segment.
Powder
Moldable
Granules
Others
A detailed breakup and analysis of the bioactive materials market based on the type has also been provided in the report. This includes powder, moldable, granules and others. According to the report, powder type accounted for the largest market share.
Dentistry
Surgery
Bioengineering
Others
The report has provided a detailed breakup and analysis of the bioactive materials market based on the application. This includes dentistry, surgery, bioengineering and others. According to the report, dentistry application exhibits a clear dominance in the market.
North America
United States
Canada
Asia Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa
The report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America was the largest market for bioactive materials. Some of the factors driving the North America bioactive materials market included the growing investment in extensive research and development (R&D) activities, the emerging healthcare infrastructure, the development of medical facilities across rural and geographically extended locations, etc.
The report has also provided a comprehensive analysis of the competitive landscape in the global bioactive materials market. Detailed profiles of all major companies have also been provided. Some of the companies covered include Arthrex Inc., BBS-Bioactive Bone Substitutes Oyj, Berkeley Advanced Biomaterials, Biomatlante SAS (Advanced Medical Solutions Group Plc), Ceraver, DePuy Synthes Inc. (Johnson & Johnson), Noraker, PULPDENT Corporation, Regenity Biosciences, etc. Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.
Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.